Details for 2018179258
Up to date per 04.04.2026
Actions
Details for 2018179258
Granted/Registered
European Patent
28.11.2018 A
26.06.2024 B1
06.02.2014
GB
201402013
19.09.2014
GB
201416622
C07D 401/14 20060101AFI20180820BHEP
Owner
Nxera Pharma UK LimitedGranta Park Great Abington Cambridge, Cambridgeshire CB21 6DGGB
Representative
No representatives present
Inventor
BROWN, Giles AlbertHeptares Therapeutics Limited Granta Park Great Abington Cambridge CB21 6DGGB
CANSFIELD, Julie ElaineHeptares Therapeutics Limited Granta Park Great Abington Cambridge CB21 6DGGB
CONGREVE, Miles StuartHeptares Therapeutics Limited Granta Park Great Abington Cambridge CB21 6DGGB
O'BRIEN, Michael AlistairHeptares Therapeutics Limited Granta Park Great Abington Cambridge CB21 6DGGB
PICKWORTH, MarkHeptares Therapeutics Limited Granta Park Great Abington Cambridge CB21 6DGGB
RACKHAM, Mark DavidHeptares Therapeutics Limited Granta Park Great Abington Cambridge CB21 6DGGB
TEHAN, Benjamin GeraldHeptares Therapeutics Limited Granta Park Great Abington Cambridge CB21 6DGGB
TEOBALD, Barry JohnHeptares Therapeutics Limited Granta Park Great Abington Cambridge CB21 6DGGB
Information about Fees